ZYXIQ
Zynex, Inc.
Price Chart
Latest Quote
$0.05
Current Price| Previous Close | $0.05 |
| Open | $0.05 |
| Day High | $0.06 |
| Day Low | $0.05 |
| Volume | 10,655 |
Stock Information
| Shares Outstanding | 30.39M |
| Total Debt | $71.62M |
| Cash Equivalents | $13.26M |
| Revenue | $108.20M |
| Net Income | $-73.96M |
| Sector | Healthcare |
| Industry | Medical Distribution |
| Market Cap | $1.52M |
| EPS (TTM) | $-2.41 |
| Exchange | PNK |
đ Custom Metrics & Score
Score: 19/42| Debt to Equity | 2.07 |
| Debt to Earnings | 0.48 |
| Current Ratio | 4.46 |
| Quick Ratio | 3.42 |
| Avg Revenue Growth | 11.91% |
| Profit Margin | 1.56% |
| Return on Equity | 8.38% |
| Avg FCF Growth | 22.88% |
| FCF Yield | 797.59% |
Score Explanation: The perfect score is 42/42 based on debt levels, profitability, growth rates, and cash flow metrics. FCF Yield is weighted most heavily as it shows what return the business currently generates.
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-02-02 | $0.05 | 10,655 |
| 2026-01-30 | $0.06 | 38,700 |
| 2026-01-29 | $0.05 | 106,200 |
| 2026-01-28 | $0.05 | 485,600 |
| 2026-01-27 | $0.07 | 163,800 |
| 2026-01-26 | $0.08 | 169,000 |
| 2026-01-23 | $0.08 | 108,000 |
| 2026-01-22 | $0.08 | 147,500 |
| 2026-01-21 | $0.07 | 118,700 |
| 2026-01-20 | $0.08 | 50,000 |
| 2026-01-16 | $0.09 | 73,300 |
| 2026-01-15 | $0.07 | 66,300 |
| 2026-01-14 | $0.08 | 32,600 |
| 2026-01-13 | $0.08 | 191,900 |
| 2026-01-12 | $0.09 | 52,600 |
| 2026-01-09 | $0.11 | 65,400 |
| 2026-01-08 | $0.11 | 149,400 |
| 2026-01-07 | $0.10 | 46,800 |
| 2026-01-06 | $0.10 | 131,300 |
| 2026-01-05 | $0.11 | 232,300 |
About Zynex, Inc.
Zynex, Inc., together with its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain, and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) device that is marketed to physicians and therapists by field sales representatives; NeuroMove, an electromyography and electric stimulation technology device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; E-Wave, an NMES device; and M-Wave, an NMES device. It also supplies private labeled products, including electrodes for the delivery of electrical current to the body; and batteries for use in electrotherapy products. In addition, the company distributes Comfortrac/Saunders for cervical traction, JetStream for hot/cold therapy, LSO Back Braces for lumbar support, braces for rehabilitation support for knee and wrist, and Dynacomp for cold compression therapy. Further, it develops Zynex Fluid Monitoring System (CM-1500); Zynex Wireless Fluid Monitoring System (CM-1600), a noninvasive monitoring device designed to measure relative changes in fluid volume in adult patients; NiCO CO-Oximeter, a laser photoplethysmographic patient monitoring device; and HemeOx tHb Oximeter, a laser-based total hemoglobin pulse oximeter. The company provides its products for use in pain management and control; stroke and spinal cord injury rehabilitation; and fluid monitoring and pulse oximetry monitoring. It sells its products through direct sales force primarily in the United States. Zynex, Inc. was founded in 1996 and is headquartered in Englewood, Colorado. On December 15, 2025, Zynex, Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Southern District of Texas.
đ° Latest News
No news articles available at the moment. Check back later for updates on ZYXIQ.
Income Statement (Annual)
Revenue
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Reconciled Cost Of Revenue | $39,429,000 | $38,366,000 | $32,005,000 | $27,321,000 |
| Cost Of Revenue | $39,429,000 | $38,366,000 | $32,005,000 | $27,321,000 |
| Total Revenue | $192,354,000 | $184,322,000 | $158,167,000 | $130,301,000 |
| Operating Revenue | $192,354,000 | $184,322,000 | $158,167,000 | $130,301,000 |
Expenses
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Interest Expense | $2,382,000 | $1,094,000 | $440,000 | $95,000 |
| Total Expenses | $186,364,000 | $173,542,000 | $135,229,000 | $107,935,000 |
| Other Income Expense | $19,000 | $2,893,000 | $-300,000 | - |
| Net Non Operating Interest Income Expense | $-2,382,000 | $-1,094,000 | $-440,000 | $-95,000 |
| Interest Expense Non Operating | $2,382,000 | $1,094,000 | $440,000 | $95,000 |
| Operating Expense | $146,935,000 | $135,176,000 | $103,224,000 | $80,614,000 |
| Selling And Marketing Expense | $86,581,000 | $86,659,000 | $67,116,000 | $54,290,000 |
| General And Administrative Expense | $60,354,000 | $48,517,000 | $36,108,000 | $26,324,000 |
Income & Earnings
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Net Income From Continuing Operation Net Minority Interest | $2,994,000 | $9,732,000 | $17,048,000 | $17,103,000 |
| Net Interest Income | $-2,382,000 | $-1,094,000 | $-440,000 | $-95,000 |
| Normalized Income | $2,978,316 | $7,504,390 | $17,279,000 | $17,103,000 |
| Net Income From Continuing And Discontinued Operation | $2,994,000 | $9,732,000 | $17,048,000 | $17,103,000 |
| Total Operating Income As Reported | $5,990,000 | $10,780,000 | $22,938,000 | $22,366,000 |
| Net Income Common Stockholders | $2,994,000 | $9,732,000 | $17,048,000 | $17,103,000 |
| Net Income | $2,994,000 | $9,732,000 | $17,048,000 | $17,103,000 |
| Net Income Including Noncontrolling Interests | $2,994,000 | $9,732,000 | $17,048,000 | $17,103,000 |
| Net Income Continuous Operations | $2,994,000 | $9,732,000 | $17,048,000 | $17,103,000 |
| Pretax Income | $3,627,000 | $12,579,000 | $22,198,000 | $22,271,000 |
| Special Income Charges | $19,000 | $2,893,000 | $-300,000 | $0 |
| Operating Income | $5,990,000 | $10,780,000 | $22,938,000 | $22,366,000 |
| Gross Profit | $152,925,000 | $145,956,000 | $126,162,000 | $102,980,000 |
Per Share Metrics
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Diluted EPS | $0.09 | $0.27 | $0.44 | $0.44 |
| Basic EPS | $0.09 | $0.27 | $0.44 | $0.45 |
Other
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Tax Effect Of Unusual Items | $3,316 | $665,390 | $-69,000 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $10,772,000 | $15,000,000 | $26,065,000 | $24,652,000 |
| Total Unusual Items | $19,000 | $2,893,000 | $-300,000 | $0 |
| Total Unusual Items Excluding Goodwill | $19,000 | $2,893,000 | $-300,000 | $0 |
| Reconciled Depreciation | $4,782,000 | $4,220,000 | $3,127,000 | $2,286,000 |
| EBITDA (Bullshit earnings) | $10,791,000 | $17,893,000 | $25,765,000 | $24,652,000 |
| EBIT | $6,009,000 | $13,673,000 | $22,638,000 | $22,366,000 |
| Diluted Average Shares | $32,299,000 | $36,142,000 | $39,127,000 | $39,196,999 |
| Basic Average Shares | $31,941,000 | $35,555,000 | $38,467,000 | $38,316,999 |
| Diluted NI Availto Com Stockholders | $2,994,000 | $9,732,000 | $17,048,000 | $17,103,000 |
| Tax Provision | $633,000 | $2,847,000 | $5,150,000 | $5,168,000 |
| Gain On Sale Of Ppe | $19,000 | $39,000 | $0 | - |
| Restructuring And Mergern Acquisition | $0 | $-2,854,000 | $300,000 | $0 |
| Selling General And Administration | $146,935,000 | $135,176,000 | $103,224,000 | $80,614,000 |
| Other Gand A | $60,354,000 | $48,517,000 | $36,108,000 | $26,324,000 |
Balance Sheet (Annual)
Assets
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Net Tangible Assets | $8,060,000 | $17,570,000 | $36,890,000 | $43,549,000 |
| Total Assets | $122,079,000 | $136,904,000 | $116,466,000 | $133,274,000 |
| Total Non Current Assets | $46,900,000 | $49,049,000 | $46,907,000 | $50,585,000 |
| Non Current Prepaid Assets | $408,000 | $409,000 | $591,000 | $585,000 |
| Non Current Deferred Assets | $4,799,000 | $3,865,000 | $1,562,000 | $711,000 |
| Non Current Deferred Taxes Assets | $4,799,000 | $3,865,000 | $1,562,000 | $711,000 |
| Non Current Accounts Receivable | $1,141,000 | $587,000 | $270,000 | $389,000 |
| Goodwill And Other Intangible Assets | $27,648,000 | $28,559,000 | $29,468,000 | $30,376,000 |
| Other Intangible Assets | $7,247,000 | $8,158,000 | $9,067,000 | $9,975,000 |
| Current Assets | $75,179,000 | $87,855,000 | $69,559,000 | $82,689,000 |
| Other Current Assets | $3,607,000 | $3,332,000 | $868,000 | $689,000 |
| Inventory | $13,919,000 | $13,106,000 | $13,484,000 | $10,756,000 |
| Receivables | $18,022,000 | $26,838,000 | $35,063,000 | $28,632,000 |
| Accounts Receivable | $18,022,000 | $26,838,000 | $35,063,000 | $28,632,000 |
| Cash Cash Equivalents And Short Term Investments | $39,631,000 | $44,579,000 | $20,144,000 | $42,612,000 |
| Cash And Cash Equivalents | $39,631,000 | $44,579,000 | $20,144,000 | $42,612,000 |
| Cash Financial | - | - | $20,144,000 | $42,612,000 |
| Prepaid Assets | - | - | - | $689,000 |
Debt
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Net Debt | $18,936,000 | $13,026,000 | - | - |
| Total Debt | $73,824,000 | $76,168,000 | $26,959,000 | $35,088,000 |
| Long Term Debt And Capital Lease Obligation | $69,507,000 | $72,243,000 | $19,022,000 | $26,778,000 |
| Long Term Debt | $58,567,000 | $57,605,000 | $5,293,000 | $10,605,000 |
| Current Debt And Capital Lease Obligation | $4,317,000 | $3,925,000 | $7,937,000 | $8,310,000 |
| Current Debt | - | - | $5,333,000 | $5,333,000 |
| Other Current Borrowings | - | - | $5,333,000 | $5,333,000 |
Liabilities
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Total Liabilities Net Minority Interest | $86,371,000 | $90,775,000 | $50,108,000 | $59,349,000 |
| Total Non Current Liabilities Net Minority Interest | $69,507,000 | $72,243,000 | $29,022,000 | $36,478,000 |
| Current Liabilities | $16,864,000 | $18,532,000 | $21,086,000 | $22,871,000 |
| Payables And Accrued Expenses | $12,547,000 | $14,607,000 | $13,149,000 | $14,561,000 |
| Payables | $7,091,000 | $9,066,000 | $7,612,000 | $10,664,000 |
| Total Tax Payable | $0 | $633,000 | $1,995,000 | $2,296,000 |
| Income Tax Payable | $0 | $633,000 | $1,995,000 | $2,296,000 |
| Accounts Payable | $7,091,000 | $8,433,000 | $5,617,000 | $4,739,000 |
| Other Non Current Liabilities | - | - | $10,000,000 | $9,700,000 |
| Dividends Payable | - | - | $16,000 | $3,629,000 |
Equity
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Common Stock Equity | $35,708,000 | $46,129,000 | $66,358,000 | $73,925,000 |
| Total Equity Gross Minority Interest | $35,708,000 | $46,129,000 | $66,358,000 | $73,925,000 |
| Stockholders Equity | $35,708,000 | $46,129,000 | $66,358,000 | $73,925,000 |
| Retained Earnings | $29,774,000 | $26,780,000 | $17,048,000 | $0 |
Other
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Treasury Shares Number | $9,856,758 | $8,545,044 | $4,253,015 | $1,246,399 |
| Ordinary Shares Number | $31,878,512 | $32,933,776 | $36,825,081 | $39,737,890 |
| Share Issued | $41,735,270 | $41,478,820 | $41,078,096 | $40,984,289 |
| Tangible Book Value | $8,060,000 | $17,570,000 | $36,890,000 | $43,549,000 |
| Invested Capital | $94,275,000 | $103,734,000 | $76,984,000 | $89,863,000 |
| Working Capital | $58,315,000 | $69,323,000 | $48,473,000 | $59,818,000 |
| Capital Lease Obligations | $15,257,000 | $18,563,000 | $16,333,000 | $19,150,000 |
| Total Capitalization | $94,275,000 | $103,734,000 | $71,651,000 | $84,530,000 |
| Treasury Stock | $87,186,000 | $71,562,000 | $33,160,000 | $6,513,000 |
| Additional Paid In Capital | $93,088,000 | $90,878,000 | $82,431,000 | $80,397,000 |
| Capital Stock | $32,000 | $33,000 | $39,000 | $41,000 |
| Common Stock | $32,000 | $33,000 | $39,000 | $41,000 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Long Term Capital Lease Obligation | $10,940,000 | $14,638,000 | $13,729,000 | $16,173,000 |
| Current Capital Lease Obligation | $4,317,000 | $3,925,000 | $2,604,000 | $2,977,000 |
| Current Accrued Expenses | $5,456,000 | $5,541,000 | $5,537,000 | $3,897,000 |
| Goodwill | $20,401,000 | $20,401,000 | $20,401,000 | $20,401,000 |
| Net PPE | $12,904,000 | $15,629,000 | $15,016,000 | $18,524,000 |
| Accumulated Depreciation | $-3,516,000 | $-2,746,000 | $-3,292,000 | $-2,642,000 |
| Gross PPE | $16,420,000 | $18,375,000 | $18,308,000 | $21,166,000 |
| Leases | $1,893,000 | $1,174,000 | $1,173,000 | $1,054,000 |
| Other Properties | $11,242,000 | $14,358,000 | $14,113,000 | $17,518,000 |
| Machinery Furniture Equipment | $3,285,000 | $2,843,000 | $3,022,000 | $2,594,000 |
| Properties | $0 | $0 | $0 | $0 |
| Inventories Adjustments Allowances | $-154,000 | $-300,000 | $-268,000 | $-152,000 |
| Other Inventories | $1,320,000 | $1,346,000 | $1,291,000 | $1,624,000 |
| Finished Goods | $7,085,000 | $6,929,000 | $7,750,000 | $4,468,000 |
| Work In Process | $143,000 | $530,000 | $1,205,000 | $345,000 |
| Raw Materials | $5,525,000 | $4,601,000 | $3,506,000 | $4,471,000 |
Cash Flow Statement (Annual)
Free Cash Flow
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Free Cash Flow | $12,143,000 | $16,550,000 | $13,328,000 | $6,340,000 |
Operating Activities
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Operating Cash Flow | $12,721,000 | $17,756,000 | $13,746,000 | $6,949,000 |
| Cash Flow From Continuing Operating Activities | $12,721,000 | $17,756,000 | $13,746,000 | $6,949,000 |
| Operating Gains Losses | $-19,000 | $-39,000 | - | - |
Investing Activities
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Capital Expenditure | $-578,000 | $-1,206,000 | $-418,000 | $-609,000 |
| Investing Cash Flow | $-578,000 | $-966,000 | $-418,000 | $-16,606,000 |
| Cash Flow From Continuing Investing Activities | $-578,000 | $-966,000 | $-418,000 | $-16,606,000 |
Financing Activities
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Repurchase Of Capital Stock | $-15,625,000 | $-37,924,000 | $-26,426,000 | $-2,667,000 |
| Financing Cash Flow | $-17,091,000 | $7,645,000 | $-35,796,000 | $13,096,000 |
| Cash Flow From Continuing Financing Activities | $-17,091,000 | $7,645,000 | $-35,796,000 | $13,096,000 |
| Net Other Financing Charges | $-1,145,000 | $-737,000 | $-352,000 | $-252,000 |
| Cash Dividends Paid | $-9,000 | $-3,000 | $-3,613,000 | $-1,000 |
| Net Common Stock Issuance | $-15,625,000 | $-37,924,000 | $-26,426,000 | $-2,667,000 |
| Common Stock Dividend Paid | - | - | $-3,613,000 | $-1,000 |
| Issuance Of Capital Stock | - | - | - | $0 |
| Common Stock Issuance | - | - | - | $0 |
Other
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Repayment Of Debt | $-334,000 | $-10,795,000 | $-5,451,000 | $-98,000 |
| Issuance Of Debt | $0 | $57,018,000 | $0 | $15,953,000 |
| Interest Paid Supplemental Data | $3,000,000 | $739,000 | $3,622,000 | $82,000 |
| Income Tax Paid Supplemental Data | $2,582,000 | $6,456,000 | $6,294,000 | $3,305,000 |
| End Cash Position | $39,631,000 | $44,579,000 | $20,144,000 | $42,612,000 |
| Beginning Cash Position | $44,579,000 | $20,144,000 | $42,612,000 | $39,173,000 |
| Changes In Cash | $-4,948,000 | $24,435,000 | $-22,468,000 | $3,439,000 |
| Proceeds From Stock Option Exercised | $22,000 | $86,000 | $46,000 | $161,000 |
| Common Stock Payments | $-15,625,000 | $-37,924,000 | $-26,426,000 | $-2,667,000 |
| Net Issuance Payments Of Debt | $-334,000 | $46,223,000 | $-5,451,000 | $15,855,000 |
| Net Long Term Debt Issuance | $-334,000 | $46,223,000 | $-5,451,000 | $15,855,000 |
| Long Term Debt Payments | $-334,000 | $-10,795,000 | $-5,451,000 | $-98,000 |
| Long Term Debt Issuance | $0 | $57,018,000 | $0 | $15,953,000 |
| Net Investment Purchase And Sale | $0 | $190,000 | $0 | - |
| Sale Of Investment | $0 | $10,000,000 | $0 | - |
| Purchase Of Investment | $0 | $-9,810,000 | $0 | - |
| Net PPE Purchase And Sale | $-578,000 | $-1,156,000 | $-418,000 | $-609,000 |
| Sale Of PPE | $0 | $50,000 | $0 | - |
| Purchase Of PPE | $-578,000 | $-1,206,000 | $-418,000 | $-609,000 |
| Change In Working Capital | $3,942,000 | $5,891,000 | $-9,102,000 | $-15,215,000 |
| Change In Other Current Assets | $0 | $-190,000 | $0 | - |
| Change In Payables And Accrued Expense | $-2,072,000 | $269,000 | $1,834,000 | $2,889,000 |
| Change In Prepaid Assets | $-66,000 | $-968,000 | $-186,000 | $453,000 |
| Change In Inventory | $-2,736,000 | $-1,445,000 | $-4,320,000 | $-3,776,000 |
| Change In Receivables | $8,816,000 | $8,225,000 | $-6,430,000 | $-14,781,000 |
| Changes In Account Receivables | $8,816,000 | $8,225,000 | $-6,430,000 | $-14,781,000 |
| Other Non Cash Items | $-1,033,000 | $-1,950,000 | $1,100,000 | $1,398,000 |
| Stock Based Compensation | $2,989,000 | $2,296,000 | $2,342,000 | $1,630,000 |
| Provisionand Write Offof Assets | $0 | $-91,000 | $82,000 | $-107,000 |
| Deferred Tax | $-934,000 | $-2,303,000 | $-851,000 | $-146,000 |
| Deferred Income Tax | $-934,000 | $-2,303,000 | $-851,000 | $-146,000 |
| Depreciation Amortization Depletion | $4,782,000 | $4,220,000 | $3,127,000 | $2,286,000 |
| Depreciation And Amortization | $4,782,000 | $4,220,000 | $3,127,000 | $2,286,000 |
| Amortization Cash Flow | $1,881,000 | $1,536,000 | $930,000 | $25,000 |
| Amortization Of Intangibles | $1,881,000 | $1,536,000 | $930,000 | $25,000 |
| Depreciation | $2,901,000 | $2,684,000 | $2,197,000 | $2,261,000 |
| Net Income From Continuing Operations | $2,994,000 | $9,732,000 | $17,048,000 | $17,103,000 |
| Gain Loss On Sale Of PPE | - | $-39,000 | $0 | - |
| Net Business Purchase And Sale | - | - | $0 | $-15,997,000 |
| Purchase Of Business | - | - | $0 | $-15,997,000 |